All Stories

Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs

Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and more than $650 million in milestones.

Jun 11, 2025 - 13:40
 0
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and more than $650 million in milestones.
Read More

Tags:

Previous Article

'The opportunities are immense': Novo Nordisk signs up to use Danish supercomputer

Next Article

EMEA-003546-PIP01-23

Related Posts

With fine-tuned AI models, OpenAI, Babylon aim to predict clinical trial successes

With fine-tuned AI models, OpenAI, Babylon aim to predi...

May 14, 2025  0

Boston Scientific’s TAVR hopes dashed again, as it pulls Acurate heart valves from global market

Boston Scientific’s TAVR hopes dashed again, as it pull...

May 28, 2025  0

Cullinan pens $700M pact for BCMA bispecific to pair with another autoimmune T-cell engager

Cullinan pens $700M pact for BCMA bispecific to pair wi...

Jun 5, 2025  0